| Product Name | MF | CAS | Details |
|---|
| Pentafluorophenyl acetate | C8H3F5O2 | 19220-93-0 | Details |
| Amino-PEG4-t-butyl ester | C15H31NO6 | 581065-95-4 | Details |
| Thalidomide | C13H10N2O4 | 50-35-1 | Details |
| Propargyl-PEG2-acid | C8H12O4 | 1859379-85-3 | Details |
| Biotin-PEG6-Thalidomide | C37H53N5O12S | 2144775-48-2 | Details |
| E3 ligase Ligand 9 | C21H32N2O6 | 87304-15-2 | Details |
| BocNH-PEG5-acid | C17H33NO9 | 890152-41-7 | Details |
| VH032-cyclopropane-F | C26H33FN4O5S | 2306193-99-5 | Details |
| cIAP1 Ligand-Linker Conjugates 12 | C46H64N4O12S2 | 2095244-52-1 | Details |
| Thalidomide-O-PEG4-azide | C23H29N5O9 | 2380318-57-8 | Details |
| 5-[(4-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, | C19H21F3N4O6 | 2412056-39-2 | Details |
| 5-[[2-(2-aminoethoxy)ethyl]amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, | C17H20N4O5 | 2412056-16-5 | Details |
| LC-2 isomer | C59H71ClFN11O7S | 2502156-12-7 | Details |
| Indisulam | C14H12ClN3O4S2 | 165668-41-7 | Details |
| Hydroxy-PEG5-t-butyl ester | C17H34O8 | 850090-09-4 | Details |
| Bromo-PEG2-acid | C7H13BrO4 | 1807503-92-9 | Details |
| t-Boc-N-amido-PEG3-CH2CO2H | C13H25NO7 | 462100-06-7 | Details |
| CC-885 | C22H21ClN4O4 | 1010100-07-8 | Details |
| E3 ligase Ligand 8 | C31H34N2O6 | 1225383-33-4 | Details |
| E3 ligase Ligand 14 | C38H52N4O7 | 2241489-43-8 | Details |
| cIAP1 Ligand-Linker Conjugates 15 | C37H47N3O8 | 1225433-96-4 | Details |
| 2-(2,6-dioxo-3-piperidinyl)-5-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]-1H-Isoindole-1,3(2H)-dione, | C21H26N4O6 | 2467424-27-5 | Details |
| Pentanoic acid, 5-[[2-(2,6-dioxo-3-piperidinyl)- 2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]amino]- | C18H19N3O6 | 2412056-33-6 | Details |
| Bestatin hydrochloride | C16H25ClN2O4 | 65391-42-6 | Details |
| Amino-PEG5-t-butyl ester | C17H35NO7 | 1446282-18-3 | Details |
| Propargyl-PEG6-acid | C16H28O8 | 1951438-84-8 | Details |
| Lenalidomide-C5-NH2 | C18H23N3O3 | 2093388-45-3 | Details |
| Pomalidomide-amido-C1-Br | C15H12BrN3O5 | 2351106-38-0 | Details |
| E3 ligase Ligand 10 | C47H52N4O7 | 1073560-68-5 | Details |
| VHL Ligand-Linker Conjugates 15 | C37H45FN4O8S | 2375564-62-6 | Details |
| 5-[(8-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, | C21H28N4O4 | 2097509-48-1 | Details |
| 5-[[2-[2-(2-aminoethoxy)ethoxy]ethyl]amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, 2,2,2-trifluoroacetate | C21H25F3N4O8 | 2412056-18-7 | Details |
| Pomalidomide | C13H11N3O4 | 19171-19-8 | Details |
| Nutlin-3a | C30H30Cl2N4O4 | 675576-98-4 | Details |
| N-Boc-O-tosylhydroxylamine | C12H17NO5S | 105838-14-0 | Details |
| Hydroxy-PEG4-t-butyl ester | C15H30O7 | 518044-32-1 | Details |
| BC-1215 | C26H26N4 | 1507370-20-8 | Details |
| Iberdomide | C25H27N3O5 | 1323403-33-3 | Details |
| (S,R,S)-AHPC-propargyl | C27H34N4O5S | 2098799-78-9 | Details |
| cIAP1 Ligand-Linker Conjugates 5 | C37H55N5O8S | 2113688-20-1 | Details |
| (S,R,S)-AHPC-PEG2-acid | C30H42N4O8S | 2172820-09-4 | Details |
| Thalidomide-O-amido-PEG4-azide | C25H32N6O10 | 2411681-89-3 | Details |
| Thalidomide-O-PEG4-Boc | C28H38N2O11 | 2411681-87-1 | Details |
| 3(2H)-dione, 5-[4-[2-(2-aminoethoxy)ethyl]-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1, | C21H27N5O5 | 2357111-29-4 | Details |
| 5-[(5-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, | C18H22N4O4 | 2307476-95-3 | Details |
| 5-[(7-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, | C20H26N4O4 | 2412056-40-5 | Details |
| Amino-PEG6-t-butyl ester | C19H39NO8 | 1286281-32-0 | Details |
| Propargyl-PEG3-acid | C10H16O5 | 1347760-82-0 | Details |
| Pomalidomide-PEG2-CO2H | C20H23N3O8 | 2140807-17-4 | Details |
| VL285 | C29H32N4O4S | 1448188-57-5 | Details |
| E3 ligase Ligand 18 | C17H17ClN6O4S | 2241669-88-3 | Details |
| cIAP1 Ligand-Linker Conjugates 14 | C39H49N3O10 | 1351169-40-8 | Details |
| Propargyl-PEG1-acid | C6H8O3 | 55683-37-9 | Details |
| BocNH-PEG4-acid | C15H29NO8 | 876345-13-0 | Details |
| cIAP1 ligand 2 | C34H40N4O6S | 2357114-70-4 | Details |
| cIAP1 Ligand-Linker Conjugates 11 | C35H43N3O7 | 1239943-19-1 | Details |
| VH032-thiol-C6-NH2 | C29H43N5O4S2 | 2098836-63-4 | Details |
| MV-1-NH-Me | C33H45N5O4 | 2095244-62-3 | Details |
| Bromo-PEG3-acid | C9H17BrO5 | 782475-35-8 | Details |
| VH032 thiol | C23H30N4O4S2 | 2098836-54-3 | Details |
| cIAP1 Ligand-Linker Conjugates 1 | C42H57N5O9S | 2357114-75-9 | Details |
| Thalidomide-O-PEG4-NHS ester | C28H33N3O13 | 2411681-88-2 | Details |
| 5-[4-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethyl]-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, | C25H35N5O7 | 2357113-68-7 | Details |
| Isopropyl 1H-imidazole-1-carboxylate | C7H10N2O2 | 82998-18-3 | Details |
| Bromo-PEG1-acid | C5H9BrO3 | 1393330-33-0 | Details |
| cIAP1 Ligand-Linker Conjugates 2 | C37H48N4O7 | 1312302-14-9 | Details |
| Lenalidomide-PEG1-azide | C17H18N6O5 | 2185795-67-7 | Details |
| Pomalidomide-PEG4-azide | C23H30N6O8 | 2271036-47-4 | Details |
| Thalidomide-O-PEG4-amine | C23H31N3O9 | 2401832-00-4 | Details |
| BocNH-PEG6-acid | C19H37NO10 | 391684-36-9 | Details |
| Hydroxy-PEG6-t-butyl ester | C19H38O9 | 361189-64-2 | Details |
| MV-1 | C33H44N4O5 | 1001600-54-9 | Details |
| Pomalidomide-PEG3-CO2H | C22H27N3O9 | 2138440-82-9 | Details |
| cIAP1 ligand 1 | C31H42N4O6S | 2095244-42-9 | Details |
| 4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]-1-Piperazinepropanoic acid, | C20H22N4O6 | 2591176-24-6 | Details |
| 1H-Isoindole-1,3(2H)-dione, 5-[[2-[2-(2-aminoethoxy)ethoxy]ethyl]amino]-2-(2,6-dioxo-3-piperidinyl)-, 2,2,2-trifluoroacetate (1:) | C21H25F3N4O8 | 2648285-33-8 | Details |
| t-Boc-N-amido-PEG1-CH2CO2H | C9H17NO5 | 142929-49-5 | Details |
| N-(3,5-Bis(trifluoromethyl)phenyl)-2-chloroacetamide | C10H6ClF6NO | 790-75-0 | Details |
| Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH | C31H44N4O11 | 2351103-63-2 | Details |
| 4-[7-(8-chloro-1-naphthalenyl)-5,6,7,8-tetrahydro-2-[(2S)-2-pyrrolidinylmethoxy]pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoro-1-oxo-2-propen-1-yl)-, (2S)- | C31H33ClFN7O2 | 2326523-41-3 | Details |
| 5-[[2-[2-(2-aminoethoxy)ethoxy]ethyl]amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, | C19H24N4O6 | 2064175-30-8 | Details |
| 5-[(6-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, 2,2,2-trifluoroacetate | C21H25F3N4O6 | 2097509-17-4 | Details |
| Bestatin-amido-Me | C17H27N3O3 | 339186-54-8 | Details |
| 4-Amino-2-(1-methyl-2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | C14H13N3O4 | 1352827-50-9 | Details |
| 3-[3-[(2S)-2-[[[7-(8-chloro-1-naphthalenyl)-4-[(3S)-3-(cyanomethyl)-4-(2-fluoro-1-oxo-2-propen-1-yl)-1-piperazinyl]-5,6,7,8 | C37H43ClFN7O5 | 2561529-98-2 | Details |
| 5-[(4-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, | C17H20N4O4 | 1957236-35-9 | Details |
| 4-[4-(6-amino-1-oxopentyl)-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, | C23H29N5O5 | 2425605-14-5 | Details |
| 2-(2,6-dioxo-3-piperidinyl)-5-[[2-(2-hydroxyethoxy)ethyl]amino]-1H-Isoindole-1,3(2H)-dione, | C17H19N3O6 | 2357113-24-5 | Details |
| 5-[(6-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, | C19H24N4O4 | 2097509-16-3 | Details |
| 1H-Isoindole-1,3(2H)-dione, 5-[[2-[2-(2-aminoethoxy)ethoxy]ethyl]amino]-2-(2,6-dioxo-3-piperidinyl)-, hydrochloride (1:1) | C19H25ClN4O6 | 2357110-58-6 | Details |
| 4-[4-(7-amino-1-oxopentyl)-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, | C24H31N5O5 | 2425605-15-6 | Details |
| TD-106 | C12H11N5O3 | 2250288-69-6 | Details |
| 5-[(3-aminopropyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, | C16H18N4O4 | 2412056-37-0 | Details |
| 4-[4-(5-amino-1-oxopentyl)-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, | C22H27N5O5 | 2425605-13-4 | Details |
| 5-[(2-aminoethyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, | C15H16N4O4 | 2307476-92-0 | Details |
| 2-(2,6-dioxo-3-piperidinyl)-5-(1-piperazinyl)-1H-Isoindole-1,3(2H)-dione | C17H18N4O4 | 2154342-61-5 | Details |
| 4-[7-(8-chloro-1-naphthalenyl)-5,6,7,8-tetrahydro-2-[[(2S)-1-(4-pentyn-1-yl)-2-pyrrolidinyl]methoxy]pyrido[3,4-d]pyrimidin-4- | C36H39ClFN7O2 | 2490716-96-4 | Details |
| Cereblon modulator 1 | C22H18ClF2N3O4 | 1860875-51-9 | Details |
| (4R,5S)-nutlin carboxylic acid | C32 H32 Cl2 N4 O6 | 2306390-08-7 | Details |
| cIAP1 Ligand-Linker Conjugates 3 | C39 H56 N4 O11 S | 2222354-20-1 | Details |
| Product Total： Product Page： | ||||
| 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 | ||||